Secondary prevention of myocardial infarction: a survey in primary care

J Cardiovasc Med (Hagerstown). 2006 Jun;7(6):422-6. doi: 10.2459/01.JCM.0000228693.07279.a1.

Abstract

Objective: To collect information on the major risk factors and secondary prevention among patients with myocardial infarction in Italy.

Methods: Data were obtained from the database of the Italian College of General Practitioners; 3588 patients (mean age 68.7 +/- 11.3 years; 2698 men, 888 women; two unrecorded gender), with an average time from event of 6 +/- 5.7 years, were identified.

Results: Among the major risk factors, data entry ranged from 50.3% for physical activity to 74.9% for blood pressure. Inadequate blood pressure control was present in 49.2% and elevated plasma cholesterol levels (> 5.2 mmol/l) in 57.3%; among the latter group, 65% were on lipid-lowering therapy. Only 47.2% of the treated patients achieved a total cholesterol level of < 5.2 mmol/l. Antiplatelet or anticoagulant drugs, beta-blockers, and angiotensin-converting enzyme inhibitors were prescribed to 43%, 10.3%, and 57.9% of patients, respectively.

Conclusions: The preventive attitude of Italian general practitioners is similar to that reported in other European countries with two noticeable exceptions: under-prescription of beta-blockers and of antiplatelet drugs. Clearly, secondary prevention requires major improvement.

MeSH terms

  • Adult
  • Aged
  • Anticoagulants / administration & dosage
  • Female
  • Humans
  • Italy
  • Lipids / blood
  • Male
  • Middle Aged
  • Myocardial Infarction / prevention & control*
  • Platelet Aggregation Inhibitors / administration & dosage
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Primary Health Care*
  • Risk Factors

Substances

  • Anticoagulants
  • Lipids
  • Platelet Aggregation Inhibitors